These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 20626200)

  • 21. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-Use Intraoperative MRI in Glioblastoma Surgery: Results of Resection, Histopathologic Assessment, and Surgical Site Infections.
    Wach J; Goetz C; Shareghi K; Scholz T; Heßelmann V; Mager AK; Gottschalk J; Vatter H; Kremer P
    J Neurol Surg A Cent Eur Neurosurg; 2019 Nov; 80(6):413-422. PubMed ID: 31272122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors triggering an additional resection and determining residual tumor volume on intraoperative MRI: analysis from a prospective single-center registry of supratentorial gliomas.
    Scherer M; Jungk C; Younsi A; Kickingereder P; Müller S; Unterberg A
    Neurosurg Focus; 2016 Mar; 40(3):E4. PubMed ID: 26926062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing the Extent of Resection and Minimizing the Morbidity in Insular High-Grade Glioma Surgery by High-Field Intraoperative MRI Guidance.
    Chen LF; Yang Y; Ma XD; Yu XG; Gui QP; Xu BN; Zhou DB
    Turk Neurosurg; 2017; 27(5):696-706. PubMed ID: 27651342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
    Combs SE; Gutwein S; Schulz-Ertner D; van Kampen M; Thilmann C; Edler L; Wannenmacher MM; Debus J
    Strahlenther Onkol; 2005 Jun; 181(6):372-7. PubMed ID: 15925979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
    Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
    World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoreductive surgery of glioblastoma as the key to successful adjuvant therapies: new arguments in an old discussion.
    Stummer W; van den Bent MJ; Westphal M
    Acta Neurochir (Wien); 2011 Jun; 153(6):1211-8. PubMed ID: 21479583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determining the utility of intraoperative magnetic resonance imaging for transsphenoidal surgery: a retrospective study.
    Coburger J; König R; Seitz K; Bäzner U; Wirtz CR; Hlavac M
    J Neurosurg; 2014 Feb; 120(2):346-56. PubMed ID: 24329023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.
    Hoffermann M; Bruckmann L; Kariem Mahdy A; Asslaber M; Payer F; von Campe G
    Clin Neurol Neurosurg; 2015 Jan; 128():60-9. PubMed ID: 25462098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
    Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
    Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment.
    Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R
    Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma.
    Gerstein J; Franz K; Steinbach JP; Seifert V; Fraunholz I; Weiss C; Rödel C
    Radiother Oncol; 2010 Dec; 97(3):382-6. PubMed ID: 20850883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-grade Glioma Surgery in Intraoperative Magnetic Resonance Imaging: Results of a Multicenter Retrospective Assessment of the German Study Group for Intraoperative Magnetic Resonance Imaging.
    Coburger J; Merkel A; Scherer M; Schwartz F; Gessler F; Roder C; Pala A; König R; Bullinger L; Nagel G; Jungk C; Bisdas S; Nabavi A; Ganslandt O; Seifert V; Tatagiba M; Senft C; Mehdorn M; Unterberg AW; Rössler K; Wirtz CR
    Neurosurgery; 2016 Jun; 78(6):775-86. PubMed ID: 26516822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
    Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of intraoperative high-field magnetic resonance imaging guidance on glioma surgery: a prospective volumetric analysis.
    Hatiboglu MA; Weinberg JS; Suki D; Rao G; Prabhu SS; Shah K; Jackson E; Sawaya R
    Neurosurgery; 2009 Jun; 64(6):1073-81; discussion 1081. PubMed ID: 19487886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative magnetic resonance imaging to reduce the rate of early reoperation for lesion resection in pediatric neurosurgery.
    Shah MN; Leonard JR; Inder G; Gao F; Geske M; Haydon DH; Omodon ME; Evans J; Morales D; Dacey RG; Smyth MD; Chicoine MR; Limbrick DD
    J Neurosurg Pediatr; 2012 Mar; 9(3):259-64. PubMed ID: 22380953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term survival after glioblastoma resection: hope despite poor prognosis factors.
    Costa E; Lawson TM; Lelotte J; Fomekong E; Vaz RG; Renard L; Whenham N; Raftopoulos C
    J Neurosurg Sci; 2019 Jun; 63(3):251-257. PubMed ID: 29363298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.